Stockscreener 앱 받기
0.8736
0.16%
-0.0014
시장 영업 전:
.87
-0.0036
-0.41%
전일 마감가:
$0.875
열려 있는:
$0.837
하루 거래량:
30.39M
Relative Volume:
3.79
시가총액:
$361.63M
수익:
$4.78B
순이익/손실:
$-284.68M
주가수익비율:
-1.2661
EPS:
-0.69
순현금흐름:
$-184.84M
1주 성능:
-48.61%
1개월 성능:
-63.45%
6개월 성능:
-73.77%
1년 성능:
-84.40%
1일 변동 폭
$0.815
$0.943
1주일 범위
$0.71
$1.82
52주 변동 폭
$0.71
$5.77
애질론 헬스 Stock (AGL) Company Profile
명칭
Agilon Health Inc
전화
562-256-3800
주소
6210 E HWY 290, AUSTIN
AGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
0.8736 | 368.84M | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
애질론 헬스 Stock (AGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-25 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-04-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-01-10 | 개시 | Needham | Hold |
| 2024-12-16 | 개시 | Macquarie | Neutral |
| 2024-12-11 | 개시 | Bernstein | Mkt Perform |
| 2024-11-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-04-22 | 개시 | Citigroup | Neutral |
| 2024-03-06 | 개시 | Barclays | Underweight |
| 2024-02-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-02-26 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-05 | 다운그레이드 | Truist | Buy → Hold |
| 2023-12-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-10-20 | 개시 | The Benchmark Company | Buy |
| 2023-06-13 | 개시 | Evercore ISI | In-line |
| 2022-12-09 | 개시 | Stifel | Buy |
| 2022-09-14 | 개시 | RBC Capital Mkts | Outperform |
| 2022-09-12 | 개시 | Goldman | Buy |
| 2022-09-07 | 재개 | Truist | Buy |
| 2022-06-24 | 개시 | BTIG Research | Neutral |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-10-20 | 개시 | Jefferies | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-05-11 | 개시 | William Blair | Outperform |
| 2021-05-10 | 개시 | BofA Securities | Buy |
| 2021-05-10 | 개시 | Deutsche Bank | Buy |
| 2021-05-10 | 개시 | Goldman | Buy |
| 2021-05-10 | 개시 | JP Morgan | Overweight |
| 2021-05-10 | 개시 | Truist | Buy |
| 2021-05-10 | 개시 | Wells Fargo | Overweight |
| 2021-05-10 | 개시 | Wolfe Research | Outperform |
모두보기
애질론 헬스 주식(AGL)의 최신 뉴스
Fibonacci Levels Suggest Recovery for agilon health inc.Capital Preserving Trade Plan Templates Shared - beatles.ru
Is a relief rally coming for agilon health inc. holdersBuy Strategy Review With Performance Summary - Newser
Visual trend scoring systems applied to agilon health inc.Growth Projection Summary for Long-Term Investors - Newser
Earnings visualization tools for agilon health inc.Free Exit Ready Momentum Stock Watchlist - Newser
Using AI based signals to follow agilon health inc.Chart Driven Entry Timing for Swing Trades - Newser
Should you wait for a breakout in agilon health inc.Intraday Strategy with Real Time Monitoring - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against agilon health, inc. (AGL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Can agilon health inc. recover in the next quarterFree Access to Real-Time Trade Insights - Newser
Barclays Lowers Agilon Health (NYSE:AGL) Price Target to $1.50 - Defense World
Agilon Health Q3 EPS Estimate Decreased by Leerink Partnrs - Defense World
Agilon Health, Inc. (NYSE:AGL) Q2 2025 Earnings Call Transcript - Insider Monkey
agilon health, inc. (NYSE:AGL) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Why agilon health inc. stock attracts strong analyst attentionAI Forecast for Trending Stocks Indicates Upside - beatles.ru
agilon health CEO steps down; interim lead appointed - MSN
Agilon Health, Inc. (NYSE:AGL) Given Consensus Rating of “Hold” by Analysts - Defense World
Agilon Health’s Earnings Call: Challenges and Optimism - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc.AGL - PR Newswire
Agilon Health Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView
Agilon Health CEO Resignation and Earnings Guidance Suspension - MSN
agilon health Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates - MSN
Citigroup Downgrades agilon health to Neutral From Buy, Adjusts Price Target to $1 From $3 - MarketScreener
agilon health, inc. Securities Lawsuit Investigation - Claim Depot
Agilon Health (NYSE:AGL) Sets New 1-Year Low Following Weak Earnings - Defense World
Agilon Health Reports Q2 2025 Results Amid Leadership Change - TipRanks
Agilon Health's Q2 2025: Key Contradictions in Growth Strategy, Risk Assessment, and Cost Management - AInvest
agilon health, inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:AGL) - Seeking Alpha
Agilon Health (AGL): Navigating Near-Term Turbulence for Long-Term Value Realization - AInvest
Agilon Health downgraded to Neutral from Buy at Citi - TipRanks
Capital World Investors Has $920.77 Million Stake in Agilon Health, Inc. (NYSE:AGL) - 富途牛牛
Agilon Health Inc (AGL) Q2 2025 Earnings Call Highlights: Strategic Initiatives and Challenges ... By GuruFocus - Investing.com Canada
agilon health inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (AGL.N) Suffers Unprecedented Intraday Drop—What's Behind the Crash? - AInvest
AGL Stock Alert: agilon health CEO Resigns; agilon Suspends Full Year 2025 Earnings GuidanceKehoe Law Firm, P.C. Investigating Potential Securities Claims - ACCESS Newswire
Agilon Health Plummets 51%—What’s Driving the Sharp Intraday Move? - AInvest
Agilon Health Missed Financial Targets And Pulled Its Forecast - Finimize
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against agilon health, inc. (AGL) And Encourages Stockholders to Reach Out - ACCESS Newswire
Johnson Fistel Commences Investigation of Agilon Health, Inc. - GlobeNewswire
Nasdaq Down 50 Points; ISM Services PMI Declines In JulyAmeresco (NYSE:AMRC), Agilon Health (NYSE:AGL) - Benzinga
Why agilon health (AGL) Stock Is Falling Today - TradingView
INVESTOR ALERT: Investigation of agilon health, inc. (AGL) Announced by Holzer & Holzer, LLC - GlobeNewswire
Agilon Health’s Hold Rating Amid CEO Resignation and Earnings Shortfall - TipRanks
Agilon Health Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact The Firm To Potentially Recover Losses - ACCESS Newswire
Dow Surges Over 100 Points; Pfizer Earnings Top Views - Benzinga
Optimistic Buy Rating for Agilon Health Amid Strategic Initiatives and Future Prospects - TipRanks
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $4 to $4 - 富途牛牛
Agilon Health’s Tumultuous Shifts: Time to Review? - timothysykes.com
Barclays lowers agilon health stock price target to $1.50 on EBITDA miss - Investing.com India
agilon health (AGL) Q2 Earnings: What To Expect - MSN
Agilon Health shares plunge after Q2 miss, leadership shakeup, and suspended guidance - MSN
애질론 헬스 (AGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
자본화:
|
볼륨(24시간):